Sandoricin

methyl 2-[(1S,3S,5S,7S,8S,9R,11S,12S,13R,16S)-5,11-diacetyloxy-13-(uran-3-yl)-16-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]acetate

FPZCLGWPFTXULY-IXRXKZEESA-N CHEBI:169093 0 Reactome links 7 studies
7 Observed studies
8 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
FPZCLGWPFTXULY-IXRXKZEESA-N
IUPAC name
methyl 2-[(1S,3S,5S,7S,8S,9R,11S,12S,13R,16S)-5,11-diacetyloxy-13-(uran-3-yl)-16-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.01,12.03,8]heptadecan-7-yl]acetate
Preferred name
Sandoricin
INN name
Synonym
ChEBI
CHEBI:169093

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles